Insulet Net Cash Flow from Operations from 2010 to 2024

PODD Stock  USD 166.25  1.52  0.92%   
Check Insulet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insulet main balance sheet or income statement drivers, such as Other Operating Expenses of 1.6 B, Operating Income of 231 M or EBIT of 154.6 M, as well as many exotic indicators such as Price To Sales Ratio of 16.14, Dividend Yield of 8.0E-4 or PTB Ratio of 20.25. Insulet financial statements analysis is a perfect complement when working with Insulet Valuation or Volatility modules.
  
This module can also supplement Insulet's financial leverage analysis and stock options assessment as well as various Insulet Technical models . Check out the analysis of Insulet Correlation against competitors.
For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.

About Insulet Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Insulet income statement, its balance sheet, and the statement of cash flows. Insulet investors use historical funamental indicators, such as Insulet's Net Cash Flow from Operations, to determine how well the company is positioned to perform in the future. Although Insulet investors may use each financial statement separately, they are all related. The changes in Insulet's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Insulet's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Insulet Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Insulet. Please read more on our technical analysis and fundamental analysis pages.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts. Insulet Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2300 people.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Insulet using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Insulet is a strong investment it is important to analyze Insulet's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insulet's future performance. For an informed investment choice regarding Insulet Stock, refer to the following important reports:
Check out the analysis of Insulet Correlation against competitors.
For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.
Note that the Insulet information on this page should be used as a complementary analysis to other Insulet's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for Insulet Stock analysis

When running Insulet's price analysis, check to measure Insulet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insulet is operating at the current time. Most of Insulet's value examination focuses on studying past and present price action to predict the probability of Insulet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insulet's price. Additionally, you may evaluate how the addition of Insulet to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Is Insulet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insulet. If investors know Insulet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insulet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
5.043
Earnings Share
2.94
Revenue Per Share
24.331
Quarterly Revenue Growth
0.379
Return On Assets
0.0609
The market value of Insulet is measured differently than its book value, which is the value of Insulet that is recorded on the company's balance sheet. Investors also form their own opinion of Insulet's value that differs from its market value or its book value, called intrinsic value, which is Insulet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insulet's market value can be influenced by many factors that don't directly affect Insulet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insulet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insulet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insulet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.